comparemela.com

Hikma Pharmaceuticals impressed the market with its annual results on Thursday as it bumped up its dividend by almost a third following double-digit growth in core revenues and profits in 2023.

Related Keywords

,Riad Mishlawi ,Shikma ,Lifts ,Dividend ,After ,Double Digit ,Growth ,2023 ,Category All ,Category Company News ,Category News And Announcements ,Category Sectorial Health Technology ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.